You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Award Disclosure
Edwards Larry Todd · SEC Form 4 · Filed Aug 25, 2026
Award
Calculated transaction value
$0
Edwards Larry Todd Chief Commercial Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Aug 24, 2026
Public filing date
Aug 25, 2026
Filing lag
Filed 1 day later
ORKA daily price context
Close on/before transaction
$102.42
Aug 24, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 20,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0000907654-26-000084
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Award | Aug 24, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA Current | Award | Aug 24, 2026 | $0 |